Utilization of sacubitril/valsartan in patients with heart failure with reduced ejection fraction: real-world data from the ARIADNE registry

U Zeymer, AL Clark, V Barrios, T Damy… - … Journal-Quality of …, 2022 - academic.oup.com
Aims To compare baseline characteristics of patients with heart failure with reduced ejection
fraction (HFrEF) initiated on sacubitril/valsartan compared with patients continued on …
被引用次数：10 相关文章

Utilization of sacubitril/valsartan in patients with heart failure with reduced ejection fraction: real-world data from the ARIADNE registry

U Zeymer, AL Clark, V Barrios… - … journal. Quality of …, 2022 - pubmed.ncbi.nlm.nih.gov
Aims To compare baseline characteristics of patients with heart failure with reduced ejection
fraction (HFrEF) initiated on sacubitril/valsartan compared with patients continued on …

Utilization of sacubitril/valsartan in patients with heart failure with reduced ejection fraction: real-world data from the ARIADNE registry

U Zeymer, AL Clark, V Barrios, T Damy… - … Journal-Quality of …, 2021 - publicum.umed.lodz.pl
Aims To compare baseline characteristics of patients with heart failure with reduced ejection
fraction (HFrEF) initiated on sacubitril/valsartan compared with patients continued on …

Utilization of sacubitril/valsartan in patients with heart failure with reduced ejection fraction: real-world data from the ARIADNE registry

U Zeymer, AL Clark, V Barrios, T Damy… - … Journal. Quality of …, 2022 - search.proquest.com
Aims To compare baseline characteristics of patients with heart failure with reduced ejection
fraction (HFrEF) initiated on sacubitril/valsartan compared with patients continued on …

Utilization of sacubitril/valsartan in patients with heart failure with reduced ejection fraction: real-world data from the ARIADNE registry

U Zeymer, AL Clark, V Barrios, T Damy… - … Journal-Quality of …, 2022 - academic.oup.com
Aims To compare baseline characteristics of patients with heart failure with reduced ejection
fraction (HFrEF) initiated on sacubitril/valsartan compared with patients continued on …

Utilization of sacubitril/valsartan in patients with heart failure with reduced ejection fraction: real-world data from the ARIADNE registry.

U Zeymer, AL Clark, V Barrios, T Damy… - … Heart journal. Quality …, 2022 - europepmc.org
Aims To compare baseline characteristics of patients with heart failure with reduced ejection
fraction (HFrEF) initiated on sacubitril/valsartan compared with patients continued on …

[引用][C] Utilization of sacubitril/valsartan in patients with heart failure with reduced ejection fraction: real-world data from the ARIADNE registry

U Zeymer, AL Clark, V Barrios, T Damy… - … Journal-Quality of …, 2022 - portalcientifico.uah.es
Aims: To compare baseline characteristics of patients with heart failure with reduced ejection
fraction (HFrEF) initiated on sacubitril/valsartan compared with patients continued on …

Utilization of sacubitril/valsartan in patients with heart failure with reduced ejection fraction: real-world data from the ARIADNE registry

U Zeymer, AL Clark, V Barrios, T Damy… - … Journal-Quality of …, 2021 - publicum.umed.lodz.pl
Aims To compare baseline characteristics of patients with heart failure with reduced ejection
fraction (HFrEF) initiated on sacubitril/valsartan compared with patients continued on …

[引用][C] Utilization of sacubitril/valsartan in patients with heart failure with reduced ejection fraction: real-world data from the ARIADNE registry

U Zeymer, AL Clark, V Barrios, T Damy… - … Journal-Quality of …, 2022 - portalcientifico.uah.es
Aims: To compare baseline characteristics of patients with heart failure with reduced ejection
fraction (HFrEF) initiated on sacubitril/valsartan compared with patients continued on …